Sold out

Method development and validation of anti-histaminic drug in plasma - Determination of fexofenadine in human plasma using Ultra Performance Liquid Chromatography

English · Paperback / Softback

Description

Read more

A selective, rapid and sensitive reverse phase ultra- performance liquid chromatography method was developed for the quantitative determination of fexofenadine in human plasma. With carbamazepine as internal standard, sample pretreatment involved a one-step extraction with ethyl acetate from 980µl plasma. The sample was analyzed using 10mM KH2PO4 buffer pH 2.5 and acetonitrile (70:30 v/v) as mobile phase. Chromatographic separation was achieved on an ACQUITY UPLC BEH (C-18) column using isocratic elution. The peak was detected using UV-PDA detector set at 210 nm and the total time for chromatographic separation was 10 min. Linear calibration curves were obtained in the concentration range of 30.09-1805.39 ng/ml with a lower limit of quantification of 30.09 ng/ml. The inter and intra- day precision (RSD) values were below 15% and accuracy (RE) was from 1.55 to 5.51 % at all QC levels. Developed method was found to be accurate, precise, selective and rapid for estimation of fexofenadine in plasma and can be used for pharmacokinetic and bioequivalence studies.

Product details

Authors Mr Maulikkuma Amin, Mr. Maulikkumar Amin, Mr.Maulikkumar Amin, Dr M M Patel, . Dr. M. M. Patel, . Dr.M.M.Patel, Deepti Jain, Dr Deept Jain, Dr. Deepti Jain, Dr.Deepti Jain, M. M. Patel
Publisher VDM Verlag Dr. Müller
 
Languages English
Product format Paperback / Softback
Released 22.08.2011
 
EAN 9783639377828
ISBN 978-3-639-37782-8
No. of pages 76
Subjects Natural sciences, medicine, IT, technology > Chemistry
Non-fiction book > Nature, technology > Natural science

Customer reviews

No reviews have been written for this item yet. Write the first review and be helpful to other users when they decide on a purchase.

Write a review

Thumbs up or thumbs down? Write your own review.

For messages to CeDe.ch please use the contact form.

The input fields marked * are obligatory

By submitting this form you agree to our data privacy statement.